Market Overview:
The global diabetes pens market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in insulin delivery devices, and rising awareness about diabetes management. The global diabetes pens market is segmented on the basis of type into reusable insulin pens and disposable insulin pens. The reusable insulin pen segment is expected to grow at a higher CAGR than the disposable insulin pen segment during the forecast period from 2018 to 2030. This can be attributed to the increasing preference for reusable over disposable devices owing to their lower cost and longer life span as compared with disposable devices. On the basis of application, the global diabetes pens market is divided into hospital & clinic, retail pharmacy, and online sales channels.
Product Definition:
A diabetes pen is a device that helps people living with diabetes to manage their blood sugar levels. The pens contain insulin, which is injected into the body, and they allow users to easily measure and administer doses of insulin. Diabetes pens are important for managing diabetes because they make it easy to accurately dose insulin, which helps keep blood sugar levels stable.
Reusable Insulin Pens:
Reusable insulin pens are devices that are used to inject insulin on a daily basis. The device consists of an integrated drug delivery system which includes a disposable needle, pen mechanism and also some type of cartridge containing the exact dose of the required insulin. The major advantage associated with these devices is that they reduce errors during injection and also minimize human assistance in performing it. These factors help patients to manage their blood glucose levels more effectively thereby improving their overall health condition.
Disposable Insulin Pens:
Disposable insulin pens and it's usage in the diabetes pens market is a device that helps to deliver short-term insulin dosage. It has an inbuilt dose counter which can be used for measuring the exact dosage. The product also comes with a memory function, which enables it to store previous doses and information as well as gives out accurate reading from them.
Application Insights:
The hospital and clinic application segment accounted for the largest share of more than 60.0% in 2017. The growing prevalence of diabetes has resulted in an increased number of patients visiting hospitals and clinics for treatment, which is expected to drive the segment growth over the forecast period. In addition, a rising number of research studies have proved that insulin pens are more effective than conventional methods such as syringes when it comes to controlling blood glucose levels in patients with diabetes mellitus. This factor is anticipated to boost demand for insulin pens at hospitals and clinics across various regions globally.
The retail pharmacy application segment accounted for a significant market share owing to increasing awareness about self-management education among consumers with diabetes who have been diagnosed by their doctor or healthcare professional with meters or glucometers that can measure blood glucose levels at home, according to their needs (targeting people who have been newly diagnosed).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers, high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region are some factors that can be attributed to its large share.
Asia Pacific is expected to grow at the fastest rate during the forecast period owing to increasing diabetic population, rising disposable income level and improving healthcare infrastructure. In addition, an increase in government initiatives such as “Make in India†campaign by Indian prime minister Narendra Modi is expected to create new growth opportunities for insulin pens manufacturers operating within this region over the next few years.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for diabetes pens, which can help in better management of the disease.
- Technological advancements: Diabetes pens are becoming increasingly sophisticated with each passing day, thanks to technological advancements. This has led to increased acceptance and demand for these devices among diabetics worldwide.
- Growing awareness about diabetes: There is a growing awareness about diabetes among people all over the world, thanks to various campaigns and initiatives by healthcare organizations and governments alike. This has resulted in an increase in demand for effective methods for managing this chronic disease, such as diabetes pens.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Pens Market Research Report
By Type
Reusable Insulin Pens, Disposable Insulin Pens
By Application
Hospital & Clinic, Retail Pharmacy, Online Sales
By Companies
Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee, Delfu, Novo Nordisk
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
127
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Pens Market Report Segments:
The global Diabetes Pens market is segmented on the basis of:
Types
Reusable Insulin Pens, Disposable Insulin Pens
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital & Clinic, Retail Pharmacy, Online Sales
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novo Nordisk
- Eli Lilly
- Sanofi
- BD
- Ypsomed Holding
- Dongbao
- Owen Mumford
- Ganlee
- Delfu
- Novo Nordisk
Highlights of The Diabetes Pens Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reusable Insulin Pens
- Disposable Insulin Pens
- By Application:
- Hospital & Clinic
- Retail Pharmacy
- Online Sales
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Pens Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes pens are a type of insulin pen that is used to administer insulin. Diabetes pens can be used to help people with diabetes manage their blood sugar levels.
Some of the key players operating in the diabetes pens market are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee, Delfu, Novo Nordisk.
The diabetes pens market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetes Pens Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diabetes Pens Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diabetes Pens Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diabetes Pens Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diabetes Pens Market Size & Forecast, 2018-2028
4.5.1 Diabetes Pens Market Size and Y-o-Y Growth
4.5.2 Diabetes Pens Market Absolute $ Opportunity
Chapter 5 Global Diabetes Pens Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diabetes Pens Market Size Forecast by Type
5.2.1 Reusable Insulin Pens
5.2.2 Disposable Insulin Pens
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diabetes Pens Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diabetes Pens Market Size Forecast by Applications
6.2.1 Hospital & Clinic
6.2.2 Retail Pharmacy
6.2.3 Online Sales
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetes Pens Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetes Pens Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diabetes Pens Analysis and Forecast
9.1 Introduction
9.2 North America Diabetes Pens Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diabetes Pens Market Size Forecast by Type
9.6.1 Reusable Insulin Pens
9.6.2 Disposable Insulin Pens
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diabetes Pens Market Size Forecast by Applications
9.10.1 Hospital & Clinic
9.10.2 Retail Pharmacy
9.10.3 Online Sales
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diabetes Pens Analysis and Forecast
10.1 Introduction
10.2 Europe Diabetes Pens Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diabetes Pens Market Size Forecast by Type
10.6.1 Reusable Insulin Pens
10.6.2 Disposable Insulin Pens
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diabetes Pens Market Size Forecast by Applications
10.10.1 Hospital & Clinic
10.10.2 Retail Pharmacy
10.10.3 Online Sales
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diabetes Pens Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diabetes Pens Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diabetes Pens Market Size Forecast by Type
11.6.1 Reusable Insulin Pens
11.6.2 Disposable Insulin Pens
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diabetes Pens Market Size Forecast by Applications
11.10.1 Hospital & Clinic
11.10.2 Retail Pharmacy
11.10.3 Online Sales
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diabetes Pens Analysis and Forecast
12.1 Introduction
12.2 Latin America Diabetes Pens Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diabetes Pens Market Size Forecast by Type
12.6.1 Reusable Insulin Pens
12.6.2 Disposable Insulin Pens
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diabetes Pens Market Size Forecast by Applications
12.10.1 Hospital & Clinic
12.10.2 Retail Pharmacy
12.10.3 Online Sales
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diabetes Pens Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diabetes Pens Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diabetes Pens Market Size Forecast by Type
13.6.1 Reusable Insulin Pens
13.6.2 Disposable Insulin Pens
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diabetes Pens Market Size Forecast by Applications
13.10.1 Hospital & Clinic
13.10.2 Retail Pharmacy
13.10.3 Online Sales
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetes Pens Market: Competitive Dashboard
14.2 Global Diabetes Pens Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novo Nordisk
14.3.2 Eli Lilly
14.3.3 Sanofi
14.3.4 BD
14.3.5 Ypsomed Holding
14.3.6 Dongbao
14.3.7 Owen Mumford
14.3.8 Ganlee
14.3.9 Delfu
14.3.10 Novo Nordisk
